QT dispersion and heart rate variability improvement with CRF antagonists to prevent sudden death
US6384039B1 · kind B1 · utility
87Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 31, 2000 |
| Grant date | May 7, 2002 |
| Priority date | — |
| Expiry date | Mar 31, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing sudden death which comprises administering to a mammal, including a human, a therapeutically effective amount of a corticotropin releasing factor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.